Amid uncertainty surrounding the Affordable Care Act and with looming midterm elections that threaten to ignite a renewed debate around health care, Lazard Senior Analyst Thomas Gallucci sees value in hospital operators with acquisition deals.
“Our favorite name in the group is Universal Health Services (UHS), and there are two key reasons behind our recommendation, and they’re both related to the company’s acquisition of Psychiatric Solutions (PSYS),” Gallucci said.
Gallucci considers UHS a “buy” for the diversification the PSYS acquisition will provide in addition to the company’s solid fundamentals and synergy opportunities. His other “buy”-rated stock is Community Health (CYH).
“Historically [CYH is] not only very strong at the blocking and tackling of the hospital business, but they also have a very good track record of buying and integrating, and ultimately running better not-for-profits,” Gallucci said. “They have a strong acquisition track record in addition to understanding the basics and running the business very well.”
Hospital or Out of Hospital Facilities: All-America Research Team Member Matt Larew Tells You Where to Invest
August 20, 2019
For-Profit Hospital Ratings on Positive Watch
September 23, 2010
Cardinal Health (CAH) Focuses on Core Hospital Supply Business, Grows Dividend
January 22, 2014
The Medicines Company (MDCO) Holds Solid Position in Hospital-Based Pharmaceuticals Market
January 28, 2015
Hospital Chain Owner Generates over $750 Million per Year in Free Cash Says Its CEO
August 20, 2019
